Search

Retina UK is a charity supporting people affected by inherited sight loss and investing in medical research to help make their challenges a thing of the past.

These are some of the most commonly asked questions about volunteering for our charity.

Nanoscope Therapeutics has announced positive results from their two year randomised controlled phase 2b optogenetic therapy trial for late-stage retinitis pigmentosa (RP).

• News
• Retinitis pigmentosa

The Great North Run is the largest half marathon in the world, taking place annually in North East England.

• Running
• Newcastle

Biotechnology company ProQR has announced that two of its RNA therapy development programmes for inherited sight loss are being acquired by Laboratoires Théa, a company specialising in eye care products.

• News

Our monthly e-Newsletter featuring the latest updates from Retina UK.

• e-Newsletter
• Audio
• Written

My name is Mark Baxter and from an early age I was diagnosed with a deteriorating retinal eye condition called retinitis pigmentosa or RP for short, which will slowly lead to blindness.

• Case study - community
• Written

Back for 2023, the virtual TCS London Marathon lets you join our team close to home and get your marathon medal!

• Running
• Close to home

Sign up to receive regular updates from Retina UK and learn more about the most innovative research and technology news, upcoming events, fundraising and support services available.

Inherited progressive sight loss is caused by a range of rare genetic conditions. We specialise in those which affect the retina.